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ABSTRACT The metabolic control of respiration is still
poorly understood, due mainly to the lack of suitable ap-
proaches for studying it in vivo. Experiments on isolated
mammalian mitochondria have indicated that a relatively
small fraction of each of several components of the electron
transport chain is sufficient to sustain a normal O2 consump-
tion rate. These experiments, however, may not ref lect accu-
rately the in vivo situation, due to the lack in the mitochondrial
fraction of essential cytosolic components and to the use of
excess of substrates in the in vitro assays. An approach is
described here whereby the control of respiration by cyto-
chrome c oxidase (COX; EC 1.9.3.1) was analyzed in intact
cultured human osteosarcoma 143B.TK2 cells and other
wild-type cells and in mitochondrial DNA mutation-carrying
human cell lines. Surprisingly, in wild-type cells, only a
slightly higher COX capacity was detected than required to
support the endogenous respiration rate, pointing to a tighter
in vivo control of respiration by COX than generally assumed.
Cell lines carrying the MERRF mitochondrial tRNALys gene
mutation, which causes a pronounced decrease in mitochon-
drial protein synthesis and respiration rates, revealed, in
comparison, a significantly greater COX capacity relative to
the residual endogenous respiration rate, and, correspond-
ingly, a higher COX inhibition threshold above which the
overall respiratory f lux was affected. The observed relation-
ship between COX respiratory threshold and relative COX
capacity and the potential extension of the present analysis to
other respiratory complexes have significant general impli-
cations for understanding the pathogenetic role of mutations
in mtDNA-linked diseases and the tissue specificity of the
mutation-associated phenotype.
The rapid accumulation of knowledge concerning mitochon-
drial diseases, especially those caused by mitochondrial DNA
(mtDNA) mutations, has stimulated in recent years a strong
interest in the metabolic control of oxidative phosphorylation
(OXPHOS). In particular, the discovery of threshold effects in
the capacity of a mtDNA mutation to produce an OXPHOS
defect in the presence of varying amounts of wild-type mtDNA
has called attention to the degree of control that a particular
step exerts in the OXPHOS pathway. It has been emphasized
that application of the metabolic control theory (1, 2) to the
study of mitochondrial metabolism can be a valuable approach
for determining the level of control exerted by different
OXPHOS steps on the rate of mitochondrial respiration (3),
and for identifying and quantifying enzymatic defects caused
in the OXPHOS machinery by mitochondrial or nuclear DNA
mutations (4–7). Recently, this approach has been applied to
isolated rat tissue mitochondria, by using increasing concen-
trations of inhibitors of complex I (rotenone), complex III
(myxothiazol or antimycin A), or complex IV (potassium
cyanide) to mimic the effects of mutations affecting these
complexes (4–7). These experiments have produced results
suggesting that the activity of each of several components of
the respiratory chain is in relatively large excess over the
amount required to support the endogenous respiration rate.
However, a limitation in the metabolic control analysis applied
to isolated mitochondria is the significant alteration of the in
vivo situation produced by the possible loss of essential me-
tabolites, especially under nonrigorous isolation conditions,
and by the disruption of the normal interactions of mitochon-
dria with cytosolic components that may play a crucial role in
channeling of respiratory substrates to the organelles. Fur-
thermore, the in vitro use of saturating concentrations of a
given respiratory substrate may alter the control exerted by the
corresponding step in the pathway. To obviate these problems,
in the present work, an approach has been developed for the
analysis of overall electron flux to oxygen in intact cells and of
the control by cytochrome c oxidase (COX; EC 1.9.3.1) of the
respiratory flux. This approach has been applied to several
types of wild-type cultured human cells and to mutant cell lines
(8) carrying the mitochondrial tRNALys gene mutation asso-
ciated with the MERRF encephalomyopathy (9). These ex-
periments unexpectedly have revealed that the wild-type cell
lines tested have only a slightly higher COX capacity than
required to support the endogenous respiration rate. Further-
more, in the mutant cell lines, a significantly greater COX
capacity relative to the residual endogenous respiration rate
was detected. These observations and their potential extension
to other respiratory complexes are relevant for understanding
the mechanisms underlying the mtDNA mutation-associated
phenotype in mitochondrial diseases and, in general, the
metabolic control of respiration.
MATERIALS AND METHODS
Cell Lines and Media. The pT1 and pT4 human cell lines,
carrying in nearly homoplasmic form the A-to-G transition at
position 8344 in the mitochondrial tRNALys gene that is
associated with the MERRF syndrome (9), and the pT3 cell
line, carrying in homoplasmic form the wild-type version of the
tRNALys gene, previously were isolated by transfer into human
mtDNA-less (r0) 206 cells of mitochondria from myoblasts of
a MERRF patient (8). The transformants were grown in
DMEM, supplemented with 10% fetal bovine serum (FBS)
and 100 mgyml bromodeoxyuridine (BrdUrd). The parental
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line of r0206, 143B.TK2 (10), was grown in DMEM with 5%
FBS and 100 mgyml BrdUrd. The cell line 701.2.8c, which is a
simian virus 40 T-antigen gene-transformed derivative (B.
Wold, personal communication) of the human fibroblast strain
GM701 (11), and HeLa cells (strain ATCC CCL2) were grown
in DMEM with 10% FBS. The r0206 cell line was grown in
DMEM with 5% FBS, 100 mgyml BrdUrd, and 50 mgyml
uridine.
DNA Analysis. Quantification of the MERRF mutation in
the mitochondrial tRNALys gene was carried out by PCR
amplification of a mtDNA segment encompassing that muta-
tion and allele-specific termination of primer extension (12)
using an appropriate 59-32P-labeled primer.
Measurements of Endogenous and [Ascorbate1 N,N,N*,N*-
Tetramethyl-p-phenylenediamine (TMPD)]-Dependent Res-
piration in Intact Cells.Exponentially growing 143B, HeLa, or
701.2.8c cells, f luid changed the day before the measurements,
were collected by trypsinization and centrifugation, and re-
suspended at 3 to 4 3 106 cells per ml in 1.5 ml of DMEM
lacking glucose, supplemented with 5% FBS, equilibrated at
378C. Other cell samples were washed once in Tris-based,
Mg21-, Ca21-deficient (TD) buffer (0.137 M NaCly5 mM
KCly0.7 mM Na2HPO4y25 mM TriszHCl, pH 7.4 at 258C), and
resuspended at 3 to 4 3 106 cells per ml in 1.5 ml of the same
buffer at 378C. Each sample was transferred into a 1.5-ml
water-jacketed chamber containing a small magnetic bar (Gil-
son), and connected to a circulating water bath at 378C and a
YS model 5300 biological oxygen monitor (Yellow Springs
Instruments), and recording of oxygen consumption was
started. The cell samples resuspended in TD buffer were read
directly and after addition of 2,4-dinitrophenol (DNP) to
25–30 mM, or of DNP and rotenone (Sigma) (100 nM), or of
DNP and antimycin A (Sigma) (20 nM), or of DNP and
potassium cyanide (KCN) (2 mM), or of DNP, antimycin A,
TMPD (Fluka) (0.1 to 2.0 mM), and sodium ascorbate (10
mM).
KCN Titration of COX Activity in Intact Cells. Exponen-
tially growing cells, f luid changed the day before, were col-
lected by trypsinization and centrifugation, and resuspended,
at either 2 to 4 3 106 cells per ml (143B, pT3) or 1 to 1.5 3
107 cells per ml (pT1, pT4), in TD buffer containing 25–30 mM
DNP for KCN titration of ‘‘integrated’’ COX activity, or in TD
buffer containing 25–30mMDNPy20 nM antimycin Ay0.2 mM
TMPDy10 mM sodium ascorbate, equilibrated at 378C, for
KCN titration of ‘‘isolated’’ COX activity. Two 1.5-ml portions
of each cell suspension were transferred into chambers at-
tached to the same circulating water bath and the same oxygen
monitor. After measurement of the starting oxygen consump-
tion rate, small amounts of a 10 mM KCN solution in H2O,
adjusted to neutral pH with HCl, were sequentially introduced
at appropriate intervals into one of the chambers near the
bottom, using a Hamilton syringe fitted with a 2.5-inch (6.3-
cm)-long needle (Hamilton). The intervals of addition were
chosen to allow adequate time for constant slope measure-
ments and to construct detailed inhibition curves. The KCN-
inhibited activity was measured after each addition of KCN
and expressed as a percentage of the uninhibited activity
measured, in parallel, in the other chamber. For the measure-
ment of (ascorbate 1 TMPD)-dependent isolated COX ac-
tivity, the oxygen consumption rate was corrected for nonspe-
cific KCN-insensitive oxidations, as recorded in a control
experiment with mtDNA-less r0206 cells, which contain no
cytochrome c oxidase and show no detectable KCN-sensitive
(ascorbate 1 TMPD)-dependent respiration.
Oxygen Consumption Measurements in Digitonin-
Permeabilized Cells. Exponentially growing 143B.TK2, pT3,
pT1, or pT4 cells were collected by trypsinization and centrif-
ugation, resuspended at 4 to 8 3 106 cells per ml in 1.5 ml of
measurement buffer (13) at 378C and transferred into a 1.5-ml
Gilson chamber. After equilibration for a few minutes, the
coupled endogenous respiration rate was measured, and dig-
itonin was added from a 10% solution in dimethyl sulfoxide to
15 mg per 106 cells. After another equilibration for 10–15 min,
sodium malate and glutamate were added to 5 mM, and, after
adequate time for accurate slope measurement, rotenone was
added to 100 nM. After maximal inhibition of O2 consumption
was reached, sodium succinate and glycerol 3-phosphate were
added to 5 mM. After an appropriate time, antimycin A was
introduced into the chamber to 20 nM, and, after maximal
inhibition of respiration was obtained, sodium ascorbate was
added to 10 mM and TMPD, to 0.2 mM (13). A parallel
experiment was carried out with the same cell suspension in the
absence of inhibitors.
RESULTS AND DISCUSSION
Measurements of Endogenous Respiration Rate. Fig. 1a
shows that the osteoblastoma-derived human cell line
143B.TK2 (10) can respire in a TrisyNaClyNaHPO4 buffer
(TD buffer), using endogenous substrates, at a rate indistin-
guishable from that observed inDMEM lacking glucose, which
often is used for O2 consumption measurements on intact cells
(14). This rate corresponds to'4.5 fmol of O2 per min per cell.
In both TD buffer and DMEM (lower-glucose) medium, the
respiration rate remains practically constant for the duration
of an oxygraphic run (not shown). Addition of DNP to the TD
buffer increases the O2 consumption rate by '35% (Fig. 1a).
In all the experiments described below, the endogenous res-
piration rate was measured in the presence of DNP, to avoid
any influence of proton cycling and OXPHOS on the respi-
ratory flux. Accordingly, in Fig. 1a and subsequent figures, the
DNP-uncoupled endogenous respiration rate is set equal to
100%. As shown in Fig. 1a, the endogenous respiration rate of
DNP-uncoupled 143B cells is nearly completely sensitive to
100 nM rotenone, 20 nM antimycin A, or 2 mM KCN, specific
inhibitors, respectively, of NADH dehydrogenase (complex I),
bc1 complex (complex III), and COX (complex IV).
Test of Isolated COX Activity in Intact Cells. By using the
above system, the isolated COX activity could be tested
polarographically by supplying the cells with 20 nM antimycin
A to suppress the electron flow in the upstream segment of the
respiratory chain, 0.2 mM TMPD as membrane-permeant
one-equivalent electron donor, and an excess (10 mM) of
ascorbate as primary reducing agent. The exclusive addition of
ascorbate to antimycin A-inhibited cells did not result in any
significant respiratory activity (not shown). It appears from
Fig. 1a that the (ascorbate 1 0.2 mM TMPD)-supported O2
consumption rate in antimycin A-inhibited, DNP-uncoupled
143B cells was only slightly lower (28%) than the uncoupled
endogenous respiration rate (Fig. 1a). This observation indi-
cated that 0.2 mM TMPD was able to reduce cytochrome c at
a rate sufficient to maintain a near-normal respiratory flux. It
also was observed that permeabilization with digitonin of
antimycin A- and (ascorbate 1 TMPD)-treated cells did not
significantly affect the O2 consumption rate supported by
ascorbate and TMPD (data not shown). This observation
argues against any significant role in the present experiments
of insufficient plasma membrane permeability to TMPD.
Fig. 1b shows a more detailed analysis of the dependence on
the concentration of TMPD (from 0 to 2 mM), in the presence
of a constant concentration of ascorbate (10 mM), of the COX
activity, measured as an isolated step, in DNP- and antimycin
A-treated 143B cells, HeLa cells, and fibroblasts of the human
cell line 701.2.8c. It appears that, in 143B cells, the TMPD
concentration is near-saturating above 2 mM, and starts
becoming limiting at '0.2 mM, as previously observed for
antimycin A-inhibited beef heart isolated mitochondria (15).
The two other human wild-type cell lines, genetically unre-
lated, gave a substantially identical titration curve for TMPD.
In the present work, a concentration of TMPD of 0.2 mM was
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chosen, because it supports a rate of respiration very close to
the endogenous one in wild-type cells and also minimizes a
possible direct electron transfer from TMPD to COX (16, 17).
KCN Titration of COX Activity in Intact Cells as Isolated
Step and as Integrated Step.COX activity was titrated with the
specific inhibitor KCN both as isolated step, using 0.2 mM
TMPD and 10 mM ascorbate as electron donors, in the
presence of antimycin A as upstream inhibitor, and as respi-
ratory chain integrated step (endogenous respiration) in the
absence of ascorbate and TMPD in non-antimycin A-treated
cells. In this way, it was possible to determine, at each
concentration of KCN used, the percentage of inhibition of the
isolated COX activity and how this inhibition affects the
respiratory flux (4, 5, 7). It had been shown by others that, in
isolated mitochondria, direct spectrophotometric titration by
KCN of the isolated COX activity supported by an excess of
reduced cytochrome c gives the same curve as the polaro-
graphic KCN titration of O2 consumption in the presence of
ascorbate and 0.2 mM TMPD (5). We verified that, in intact
143B cells, the sensitivities to KCN of the isolated COX
activity promoted by 0.2 mM and by 1.0 mM TMPD, as
measured versus increasing concentrations of the inhibitor,
were substantially identical (within 10%) (data not shown).
Furthermore, to exclude the possibility that an intracellular
accumulation of the oxidized form of TMPD during the
titration experiment would interfere with the KCN sensitivity
measurements, the effect of each KCN concentration on the
initial rate of (ascorbate 1 TMPD)-supported O2 consump-
tion was analyzed. Again very similar results were obtained in
the presence of 0.2 mM and 1.0 mM TMPD (data not shown).
Fig. 2 shows that the KCN titration curve, in the presence of
ascorbate and TMPD, of antimycin A-inhibited 143B cells was
quasilinear for nonsaturating concentrations of the inhibitor.
On the other hand, the variation of the endogenous respiration
rate over the same range of KCN concentrations produced a
curve that was clearly sigmoidal in shape. Very similar results
were obtained in experiments carried out in the absence of
DNP (data not shown). The difference in the KCN titration
curves of COX activity as isolated step and as respiratory chain
integrated step was consistent with the occurrence in 143B
cells of an excess of COX activity over that required to
maintain a normal O2 consumption rate. However, this excess
appeared to be significantly lower than previously reported for
isolated rat tissue mitochondria (4, 5, 7), suggesting a tighter
in vivo control of respiration by COX in 143B cells than
previously assumed.
The availability of 143B.TK2 cell derivatives carrying in
their mtDNA various proportions of the tRNALys gene muta-
tion associated with the MERRF encephalomyopathy pro-
duced by introducing mitochondria from myoblasts of a
MERRF patient into mtDNA-less (r0) 143B.TK2 cells (8),
offered the opportunity for investigating how the respiratory
flux control by COX was affected in cells containing different
levels of residual COX activity spared by the mutation. The
pT1 cell line virtually lacks wild-typemtDNA. The pT4 cell line
contains only 6.6% wild-type mtDNA, which is very close to
the genetic protective threshold (18), and the pT3 cell line is
apparently free of mutant mtDNA (8). The endogenous
respiration rate of pT1 cells was found to be '8%, and that of
pT4 cells, '24% of the 143B rate, whereas pT3 cells exhibited
a respiratory activity comparable to that of the parental
wild-type cell line (8) (see also Table 1). As shown in Fig. 2,
the KCN inhibition curves for the isolated COX activity of pT1
and pT4 cells were very similar to that observed for 143B cells,
whereas, in pT3 cells, the isolated COX appeared to be less
sensitive to the inhibitor. While it is not known whether this
lower sensitivity of the isolated step in pT3 cells reflected a
decreased permeability of the cells to the inhibitor or another
FIG. 1. Measurements of endogenous respiration rate or (ascorbate1 TMPD)-dependent respiration rate by intact 143B.TK2 cells. (a) Relative
oxygen consumption rate by cells in DMEM lacking glucose, or in TD buffer in the absence or presence of DNP, or in TD buffer in the presence
of DNP and either rotenone (Rot) or antimycin A (Ant) or KCN, or in TD buffer in the presence of DNP, antimycin A, ascorbate, and 0.2 mM
TMPD. The data represent the means 6 SE obtained in two determinations made in DMEM (2glucose) or TD, 7 determinations in TD1DNP,
one determination in TD1DNP1rotenone, or in TD1DNP1antimycin A, or in TD1DNP1KCN, and 12 determinations in TD1DNP, antimycin
A, ascorbate, and 0.2 mM TMPD. (b) Dependence on concentration of TMPD, in the presence of a constant concentration of ascorbate, of the
initial oxygen consumption rate associated with isolated COX activity in DNP- and antimycin A-treated 143B.TK2 cells (F), HeLa cells (h), and
the fibroblast cell line 701.2.8c (), expressed as a percentage of the endogenous rate. The data shown represent the means 6 SE obtained in 2–12
determinations on 143B cells tested at each of different concentrations of TMPD (the error bars that fall within the individual data symbols are
not shown), or the results of single determinations on HeLa cells or 7012–8c cells.
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nuclear gene-controlled change(s), occurring presumably in
the original r0 recipient cell, it was expected that a lower
sensitivity to the inhibitor also would be exhibited by the KCN
titration curve of the endogenous respiration rate of pT3 cells.
Indeed, as shown in Fig. 2, the relative sensitivities to KCN of
the endogenous respiration rate and of the isolated enzyme
activity in pT3 cells were very similar to those found in 143B
cells, with the titration curve of the endogenous respiration
rate exhibiting a near-sigmoidal shape. By contrast, the KCN
titration curve of the endogenous respiration rate of pT1 cells
indicated a pronounced decrease in sensitivity as compared
with 143B cells, while the titration curve of pT4 cells exhibited
an intermediate behavior (Fig. 2).
Determination of COX Respiratory Threshold. The differ-
ence between the mutant cell lines pT1 and pT4 and the
wild-type cell lines 143B and pT3 in the relative KCN sensi-
tivities of the endogenous respiration rate and of the isolated
COX activity are best illustrated by a threshold plot (5, 7, 19),
i.e., a plot of the relative endogenous respiration rate of 143B
cells and of the pT3, pT4, and pT1 r0 cell transformants against
percent inhibition of isolated COX activity by the same KCN
concentrations. In this plot, the endogenous respiration rate
remains fairly constant with increasing inhibition of the iso-
lated enzyme, up to the percent inhibition (threshold) at which
a further decrease in enzyme activity has a marked inhibitory
effect on the rate of endogenous respiration. It is clear from
Fig. 3a that the thresholds of COX inhibition above which the
respiratory flux starts decreasing are higher in the mutant cell
lines pT1 and pT4 than in the wild-type cell lines 143B and pT3.
In particular, the estimated values are '28% in 143B cells,
'21% in pT3 cells,'51% in pT4 cells, and'82% in pT1 cells
(indicated by arrows in the expanded plots of Fig. 3 b–d; see
also Exp. 1 in Table 1).
Determination of Relative COX Capacity in Intact Cells. In
the expanded plots of Fig. 3, the least-square regression lines
through the filled symbols beyond the inflection point in each
curve are extrapolated to zero COX inhibition. The intersec-
tions of these lines with the ordinate axis give estimates of the
maximum COX capacity as integrated step, expressed as
percentages of the uninhibited endogenous respiration rate
(Fig. 3 b–d; see also Exp. 1 in Table 1). One can see that the
maximumCOX capacity is only 1.4 times and 1.27 times as high
as the endogenous respiration rate in 143B cells and, respec-
tively, pT3 cells (Table 1), whereas it is twice the endogenous
respiration rate in pT4 cells and 5.2 times as high in pT1 cells.
The equations describing these extrapolated lines conform to
the general formula:
COXRi 5 COXRmax(100 2 x) [1]
where x represents the percent inhibition of COX activity at [i]
concentration of inhibitor, as detected by KCN titration of the
isolated step (Fig. 2), COXRi represents the endogenous
respiration rate at [i] concentration of inhibitor, expressed as
percentage of the uninhibited endogenous respiration rate,
and COXRmax represents the ratio of the maximum COX
capacity to the uninhibited endogenous respiration rate. The
threshold value of x at which COXRi 5 uninhibited endogenous
respiration rate (5100) can be calculated fromEq. 1 as follows:
COXThreshold 5 100[1 2 (1yCOXRmax)] [2]
where COXRmax is defined above. Hereafter, COXRmax is de-
fined as relative capacity of COX.
In the TMPD titration curve for 143B cells shown in Fig. 1b,
the relative uncoupled respiration rate supported by 0.4 mM
TMPD in the presence of antimycin A reached a value of 1.39
(indicated by a dashed line), which is almost identical to the
COXRmax value previously determined by extrapolation of the
KCN inhibition data in the threshold plot of Fig. 3b to zero
COX inhibition (1.40). It is worth noticing that the relative
uncoupled respiration rate of two other, genetically unrelated,
human wild-type cell lines (HeLa cells and 701.2.8c cells)
reached at 0.4 mM TMPD a very similar value (Fig. 1b). These
observations suggested the possibility that titration of the
relative uncoupled respiration rate at 0.4 mM TMPD in
antimycin A-treated cells would provide a simplified approach
for the estimation of the COXRmax and, therefore, of the COX
respiratory threshold by Eq. 2 given above. This possibility was
verified by determining the ratios of (ascorbate 1 0.4 mM
TMPD)-dependent respiration rate to endogenous respiration
rate in intact antimycin A-treated pT1 and pT4 cells in TD 1
DNP. As shown in Table 1 (Experiments 1 and 2), the latter
ratios were very similar, within 10%, to the values for COXRmax
determined by extrapolation of the COX inhibition data in the
threshold plots of Figs. 3 c and d. The observation that the
relative uncoupled respiration rate supported by 0.4 mM
TMPD in the presence of antimycin A reached in intact cells
of several cell lines a value very close to the COXRmax value
determined by extrapolation of the KCN inhibition data is in
full agreement with the previous finding that, in beef heart
submitochondrial particles, the steady-state level of reduction
of cytochrome c reached a maximum at'0.4 mM TMPD (17).
Presumably, any increase in O2 consumption rate occurring in
the presence of concentrations of TMPD .0.4 mM reflects
direct electron transfer (16, 17) to the cytochrome c oxidase.
Also shown in Table 1 are the results of experiments in which
the value of COXRmax was experimentally modified in 143B
cells by exposing them to a low concentration of rotenone ('3
nM) or antimycin A ('2.7 nM) to decrease the rate of their
endogenous respiration. It is clear that both rotenone and
antimycin A increase the COX respiratory threshold and the
COXRmax to values intermediate between those observed in
FIG. 2. Inhibition by KCN of endogenous respiration rate in TD
buffer in the presence of DNP (E), or of (ascorbate 1 0.2 mM
TMPD)-dependent respiration rate in TD buffer in the presence of
DNP and antimycin A (F), in intact 143B.TK2 cells and transmito-
chondrial human cell lines carrying mtDNA with the mitochondrial
tRNALys gene mutation (pT1, pT4) or wild-type mtDNA (pT3),
derived from a patient affected by the MERRF encephalomyopathy
(8). The data shown represent the means6 SE obtained in six or seven
determinations on 143B cells, three determinations on pT1 cells, and
four determinations on pT4 cells (the error bars that fall within the
limits of the individual data symbols are not shown), or the results of
a single determination on pT3 cells.
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pT4 and pT1 cells. Furthermore, here too, the values for
COXRmax determined by extrapolation to zero COX inhibition
of the KCN inhibition data in the partially rotenone- or
antimycin A-inhibited cells are very similar to the ratios of
(ascorbate 1 0.4 mM TMPD)-dependent respiration rate to
endogenous respiration rate determined under the same con-
ditions.
Relationship of COX Respiratory Threshold to Relative
COX Capacity. This relationship, described by Eq. 2, has
important implications for the metabolic control of respira-
tion. Fig. 4 shows a plot of the COX respiratory thresholds
(derived from the KCN inhibition data) versus the indepen-
dently determined ratios of (ascorbate 1 0.4 mM TMPD)-
dependent respiration rate to endogenous respiration rate,
used as estimators of COXRmax, in intact 143B, pT1, and pT4
cells, as well as in 3 nM rotenone- or 2.7 nM antimycin
A-treated 143B cells. The theoretical value of COX threshold
(5 0) expected for COXRmax 5 1 also is plotted. The curve
shown corresponds to Eq. 2, and one can see that it fits very
closely the independently determined experimental data. The
observed relationship between COX threshold and relative
COX capacity indicates that, in the low range of relative COX
capacities (between 1 and 2), any physiological change or
inhibitor action or mutation that affects, even moderately, the
FIG. 3. Percentage of endogenous respiration rate as a function of
percent of COX inhibition in intact 143B.TK2 cells (E) and pT1 (M),
pT3 (L), and pT4 () transmitochondrial cell lines (a), and maximum
COX capacity in 143B.TK2 (b), pT1 (c), and pT4 cells (d). (a) The
values (either means 6 SE obtained in several experiments with
143B.TK2 cells, pT1, and pT4 cells shown in Fig. 2, or values obtained
in a single experiment with pT3 cells) for percent of endogenous
respiration rate and percent of COX inhibition at each KCN concen-
tration are plotted against each other. (b–d) The percent rates of
endogenous respiration in the experiments using 143B, pT1, and pT4
cells illustrated in a are plotted against percent of COX inhibition by
KCN, and the least-square regression line through the symbols (filled)
beyond the inflection point of each curve (arrow) is extended to zero
COX inhibition. The equations describing these extrapolated lines and
the probability of the data fitting are shown.
FIG. 4. Relationship of COX respiratory threshold (COXT) to
relative COX capacity. The data for COX thresholds derived from the
COX inhibition data in wild-type 143B and pT3 cells, mutant pT1 and
pT4 cells (Fig. 3 and Table 1), and 3 nM rotenone- or 2.7 nM antimycin
A-treated 143B cells (Table 1) are plotted against the ratios of
(ascorbate 1 0.4 mM TMPD)-dependent O2 consumption rate to
endogenous respiration rate (TMPD 0.4 mM/endog. resp.).
Table 1. COX threshold, relative COX capacity (COSRmax), endogenous respiration, and activities of respiratory enzymes in 143B cells and
their mutant derivatives and in partially rotenone- or antimycin A-inhibited 143B cells





1 COX threshold, % 28.2 21.3 51.2 82.2 75.2 63.1
COXRmax 1.40 1.27 2.00 5.20 3.96 2.69
2 Respiration rate ratio,
(ascorbate 1 TMPD) to endogenous 1.39 6 0.03 1.20 6 0.04 2.06 6 0.06 5.58 6 0.11 3.60 2.50
3 Respiration rate, fmol O2yminycell
Endogenous 4.47 (4.54) 4.70 (4.70) 1.02 (1.06) 0.34
Substrate-dependent*
Glutamate 1 malate 2.82 (3.06) 1.88 (2.27) 0.33 (0.37) 0.06
Succinate 1 G-3-P 3.88 (4.99) 2.83 (3.70) 1.14 (1.38) 0.50
Ascorbate 1 TMPD 4.24 (6.36) 3.86 (5.13) 1.63 (2.20) 1.44
Experiment 1. Data taken from experiments of Fig. 3 and similar experiments carried out with pT3 cells and with 143B cells partially inhibited
in their respiration by 3 nM rotenone or 2.7 nM antimycin A. Experiment 2. Data taken from experiment of Fig. 1b with 143B cells and similar
experiments carried out with the pT3 wild-type mtDNA-carrying transformant, the pT1 and pT4 MERRF mutation-carrying transformants, and
143B cells partially inhibited by 3 nM rotenone or 2.7 nM antimycin A. The data represent the means 6 SE obtained in three determinations on
143B or pT3 or pT1 or pT4 cells, and the results of single determinations on rotenone- or antimycin A-treated cells. TMPD was 0.4 mM. Experiment
3. The data shown represent the respiration rates supported by endogenous substrates or added substrates (expressed in fmol of O2 per min per
cell), using rotenone at 100 nM or antimycin A at 20 nM to block respiration supported by glutamate1malate or succinate1 glycerol 3-phosphate
(G-3-P), respectively, or, in a parallel experiment, without inhibitors (in parentheses). TMPD was 0.2 mM.
*Digitonin-permeabilized cells.
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activity of a component of the respiratory chain upstream of
COX or the activity of COX may produce dramatic changes in
the COX threshold, and, therefore, in the control of respira-
tion by COX. These findings and their potential extension to
other respiratory complexes are significant for understanding
the pathogenetic role of disease-causing mtDNA mutations
that produce only a moderate decrease in the activity of a given
component of the respiratory chain (20–23), and for elucidat-
ing the basis of the striking tissue specificity of the mutation-
associated phenotype (24).
Polarographic Analysis of Activity of Respiratory Com-
plexes in Digitonin-Permeabilized Cells. In the case of the cell
lines carrying the MERRF mutation (pT1 and pT4), the
significant increase in their COX thresholds, as compared with
those of cell lines carrying the same nuclear background (143B
and pT3), and even the same mtDNA apart from the mutation
(pT3), clearly indicates that COX exerts only a low level of
control on the respiratory chain of these mutant cells. To
obtain evidence about the rate-limiting step in the respiration
of these cells, a polarographic analysis of the activity of the
respiratory complexes was carried out in cells permeabilized
with digitonin. As shown in Table 1 (Exp. 3), in pT4 and pT1
cells, the rotenone-sensitive (glutamate 1 malate)-dependent
O2 consumption rate was decreased, relative to 143B cells, by
88% and 98%, respectively, whereas the antimycin A-sensitive
(succinate1 glycerol 3-phosphate)-dependent respiration rate
was decreased by 71% and 87%, and the KCN-sensitive
(ascorbate 1 0.2 mM TMPD)-dependent respiration rate, by
62% and 66%. Furthermore, in non-rotenone-inhibited pT4
cells, the O2 consumption rate in the presence of glutamate,
malate, succinate, and glycerol 3-phosphate was significantly
higher than the coupled endogenous respiration (1.38 vs. 1.06),
indicating that complex III was not rate-limiting in these cells.
It is, therefore, clear from these observations that, in MERRF
mutation-carrying cells, the activity of complex I is the rate-
limiting step. This agrees with the finding of an undetectable
labeling of the largest mtDNA-encoded subunits of this com-
plex, ND4 and ND5, in [35S]methionine pulse-labeled mutant
cells (8, 25).
The data of Exp. 3 in Table 1 are also relevant to the general
question of how closely O2 consumption measurements carried
out on isolated mitochondria or digitonin-permeabilized cells
reflect the in vivo situation. In particular, one can see that the
state 3 (glutamate 1 malate)-dependent respiration rate mea-
sured in digitonin-permeabilized cells in two parallel experi-
ments was only 63% to 67%, 40% to 48%, 32% to 35%, and
18% of the coupled endogenous respiration in 143B, pT3, pT4,
and pT1 cells, respectively. It is particularly significant that,
after permeabilization with digitonin, the (glutamate 1
malate)-dependent respiration rate in 143B cells was 63% to
67% of the coupled endogenous respiration rate, whereas the
(ascorbate 1 0.2 mM TMPD)-dependent respiration rate was
practically unaffected, as previously mentioned. These obser-
vations indicate that, under the above conditions, which would
be expected to affect the environment of mitochondria much
less dramatically than the isolation of the organelles, the
relative COX capacity of 143B and pT3 cells was already
significantly increased, as compared with the values in intact
cells. In fact, one can estimate values of relative COX capacity
of '2.2 and '3.1 by dividing the O2 consumption rate
expected, on the basis of the data in Fig. 1b, in digitonin-
permeabilized, antimycin A-treated 143B and pT3 cells, re-
spectively, if the TMPD concentration were increased from 0.2
mM to 0.4 mM, by the (malate 1 glutamate)-dependent
respiration rate in the same cells. It also should be noticed that,
in Exp. 3 in Table 1 carried out in the absence of inhibitors, in
which the endogenous electron flux was anticipated to increase
the level of cytochrome c reduction, the (ascorbate 1 0.2 mM
TMPD)-dependent respiration rate measured in digitonin-
permeabilized 143B and pT3 cells was also more than double
(2.1 and 2.3 times, respectively) the (glutamate 1 malate)-
dependent respiration rate in the same cells. These observa-
tions, which agree with other reports on O2 consumption
measurements in intact and digitonin-permeabilized cells (21,
26, 27), emphasize the value of in vivomeasurements for better
understanding the role of developmental, physiological, or
pathological factors in the metabolic control of respiration.
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